PremiumThe FlyImmunityBio reports Q1 EPS (15c), consensus (14c) Biotech Alert: Searches spiking for these stocks today Largest borrow rate increases among liquid names PremiumThe FlyImmunityBio announces long-term results from QUILT-3.032 study Short Report: Bears bite into solar with higher exposure to Sunrun, SolarEdge ImmunityBio’s Promising Advances in Cancer Treatment Bolster Buy Rating PremiumThe FlyLargest borrow rate increases among liquid names ImmunityBio announces 1st dosing of rBCG in U.S. and 60 sites pending Largest borrow rate increases among liquid names 
